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In Brief
Ortiz et al. have found that a subset of the total CaMKIIa mRNA population retains an intron in dendrites. Staufen2 interacts with this intron and enhances the distal dendritic localization of unspliced CaMKIIa mRNA. These findings suggest that intron retention could be a mechanism to modulate dendritic localization of synaptic mRNAs.
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INTRODUCTION
The targeting of mRNAs to dendrites requires the recognition of cis-localization elements (LEs) by RNA-binding proteins (RBPs) (Ule and Darnell, 2006) , usually as part of a larger complex of ribonucleoproteins (RNPs), also known as neuronal RNA granules (Buchan, 2014; Kiebler and Bassell, 2006) . Several recent studies have consolidated the notion that many introns are actively retained in mature mRNAs (Bell et al., 2010; Wong et al., 2013; Yap et al., 2012) . To investigate the contribution of intron retention to cytoplasmic mRNA distribution, we decided to perform an intron disequilibrium analysis in dendritically localized mRNAs. Since CaMKIIa has a central role in neuronal signaling (Hell, 2014) and recent genome-wide studies have shown intronic sequences retained in CaMKIIa mRNAs from neuronal samples (Braunschweig et al., 2014) , we decided to focus our study on this important dendritic transcript. Here, we demonstrate the presence of CaMKIIa mRNA molecules retaining intron i16 in dendrites, RNA granules, and synaptoneurosomal fractions, the presence of i16 being predominant in distal dendrites depending on synaptic activation. Our study shows that synaptic activation downregulates i16-containing CaMKIIa mRNA in a mechanism that depends on its translation. Notably, this i16-containing transcript specifically interacts with Staufen2 (Stau2), a well-known RBP involved in the targeting of mRNAs to neuronal dendrites (Heraud-Farlow and Kiebler, 2014) . As Stau2 is important in enhancing dendritic localization of intron-i16-containing CaMKIIa mRNA, our findings suggest that intron retention could have key roles in the assembly and stabilization of an mRNA subpopulation to fine-tune CaMKIIa activity at synapses.
RESULTS
Intron Disequilibrium Analysis of CaMKIIa
To investigate the contribution of intron retention in modulating CaMKIIa mRNA function, we performed an intron disequilibrium analysis with probes located at exon-intron junctions ( Figure 1A ). We initially focused on two introns (i14 and i16) previously shown to be involved in intron retention and alternative splicing (Braunschweig et al., 2014) , while i9 and i11 were used as controls. Using RNA from embryonic day 17 (E17) cortical cultures and adult mouse brain, we found that i16-containing transcripts were the most abundant compared with other intron-containing transcripts in total cell extracts and synaptoneurosomes from cortical cells and brain ( Figures 1B, 1D , S1A, and S1B). Sequences around both the 5 0 and 3 0 splice sites of intron i16 were similarly enriched in samples from mouse brain (Figure S1D) , making alternative transcription termination events within intron i16 unlikely. We also observed an increased presence of i14-containing transcripts in embryonic samples, cortical and hippocampal cells obtained from 17-day embryos, compared to adult brain, suggesting a putative role of i14 during development ( Figures 1B, 1D , S1A, and S1B). Next, we extended the analysis to all CaMKIIa introns in synaptoneurosomes from cortical cultures and RNA granules from brain (Figures 1C and 1E) . In both fractions, we found higher levels of i16-containing transcript compared with other intron-containing RNAs. Our data are consistent with a recent high-throughput RNAsequencing analysis (Braunschweig et al., 2014 ) that shows i16 (B-E) Intron disequilibrium by qRT-PCR analysis. All probes were made relative to genomic DNA to correct for differences in primer efficiency. RNA was obtained from (B) 14 days in vitro (DIV) cortical cell culture cytoplasmatic fraction, (C) synaptoneurosome fraction from cortical cells (obtained by Percoll gradient), (D) nucleus-free mouse brain extract, and (E) RNA granule fraction from mouse brain. Each bar corresponds to an independent experiment and represents the relative mean value from three independent qRT-PCR measurements. Confidence limits (a = 0.05) are also shown. The boxes in (C)-(E) show representative western blots of PSD-95, histone H3, and hnRNPA2/B1 from total cell extracts (CE), input (S1-S3), or synaptoneurosomes (Syn) and RNA granule (P3) fractions. (F) Sequence alignment of the first 120 nt of CaMKIIa intron i16 from mouse, human, and rat. (G) Scheme of CaMKIIa mRNA long (L) and short (S) isoforms. Colored arrows represent primers used for semiquantitative PCR analysis. (H) Semiquantitative PCR using cDNA from mouse nucleus-free brain extracts. Primer efficiency was assessed by equimolar template amplification. retention in samples of human and mouse neuronal origin, being particularly high in Neuro-2a neuroblastoma cells, a finding consistent with our observations ( Figure S1C ). Another study in rat isolated dendrites also showed cytoplasmic retention of intron i10 (the rat equivalent to mouse i16), although with a moderate p value (0.076) (Buckley et al., 2011) .
Sequence alignment revealed that the first 120 nt of intron i16 are 86.3% identical when comparing rodents and humans ( Figure 1F ), which indicates an extremely high conservation compared to other intronic sequences ( Figure S1E ). In contrast, amino acid sequences that arise from the 5 0 end of i16 are not particularly conserved ( Figure S1F ), suggesting conserved mechanisms at the transcript level. CaMKIIa has two main mRNA isoforms in mice, a long isoform that encodes the whole CaMKIIa protein and a short isoform that only includes the C-terminal association domain responsible for assembly of CaMKIIa subunits into large multimers. To determine whether i16 is retained in long or short CaMKIIa transcript isoforms, we performed a semiquantitative PCR analysis using cDNA from mouse nucleus-free brain extracts ( Figure 1D , inset, fraction S2) and found that i16 is mainly retained in the long isoform ( Figures 1G and 1H ).
Subcellular Localization and Stimulation-Mediated Downregulation of i16-Containing CaMKIIa mRNA
We used high-resolution fluorescent in situ hybridization (FISH) to study the localization of i16 transcripts in hippocampal neurons and designed a software plugin (see Experimental Procedures) to quantify foci fluorescence and localization in soma and dendrites. As previously observed (Cajigas et al., 2012) , mature CaMKIIa mRNAs are very abundant in both soma and dendrites as detected with an exonic probe ( Figures S2A-S2C) . Notably, the i16 probe produced foci with similar fluorescence intensity when compared to the exonic probe, although at a much lower number. We observed 15% of co-localization between the two probe sets, which increased to 40% after 3 min of pepsin treatment ( Figure S2D ), suggesting that both RNA target sequences are present in the same RNA molecule but masked by a proteinaceous complex as previously described for other dendritic mRNAs (Buxbaum et al., 2014) . To facilitate the quantification of dendritic mRNAs, we used microfluidic chambers that compartmentalize soma and neurites and, using this approach, we observed a gradient distribution pattern throughout the somatodendritic compartment for both exonic and intronic foci ( Figure 2A ). Overexposed Map2 signal shows that both exonic and intron16 foci are present in dendrites ( Figure 2B ). The i16-containing mRNA represented 3.7% ± 0.33% of the total CaMKIIa mRNAs in the somatic cytoplasm. Interestingly, our analysis showed that the percentage of i16-unspliced versus spliced isoforms increased with dendritic distance reaching 28.4% in distal dendrite segments (>200 mm) ( Figure 2C ).
If i16-containing mRNA is a component of RNA granules, synaptic stimulation might be expected to alter its levels in dendrites. We found that either BDNF or NMDA stimulation produced a significant decrease in i16-containing mRNA by both qRT-PCR in functional synaptoneurosomes ( Figure 2D ) and high-resolution FISH in hippocampal neurons ( Figure 2E) . Notably, the BDNF effect was abolished by cycloheximide (Figure 2F) , a protein synthesis inhibitor, indicating that downregulation of intron containing mRNA upon stimulation depends on translation as it has been reported for transcripts that are degraded by the mRNA nonsense-mediated decay (NMD) pathway, such as the Arc mRNA ( Figure S2E ). On the contrary, spliced CaMKIIa mRNA levels were not affected by BDNF treatment ( Figure 2G ). These results point to a specific action of BDNF in the downregulation of i16-containing mRNA.
Intron 16 Interacts with Components of RNA Granules in Dendrites
Since the i16-containing mRNA isoform is differentially localized to distal dendrites, we decided to test whether intron i16 would share interactors with the fully spliced CaMKIIa mRNA. To test this possibility, we performed an RNA immunoprecipitation (RIP) analysis in Neuro-2a cells using the MS2 tagging system. While RIP efficiencies of i16 and control ZsGreen-fusion RNAs were similar ( Figure S3A ), we found that CaMKIIa mRNA was significantly enriched in the i16 RIP compared to control (Figure 3A) , suggesting that i16-unspliced and spliced CaMKIIa mRNAs would share protein interactors. In addition, we found that neurons overexpressing intron i16 displayed a substantially higher number of dendritic CaMKIIa mRNA foci (2-fold) compared to control neurons ( Figure 3B and 3C). Since the i16-containing construct does not contain the CaMKIIa 3 0 UTR, shared protein interactors would depend on specific LEs present in intron i16, as reported for others introns (Buckley et al., 2011) . Alternatively, if the increased numbers of dendritic CaMKIIa mRNA foci contain i16, our data would point to protein interactions bridging i16-containing mRNA molecules.
Staufen (Stau) proteins belong to a family of RBPs that are critical for targeting specific mRNA in neurons (Heraud-Farlow and Kiebler, 2014; Monshausen et al., 2004; Tang et al., 2001) . Given that dendritic CaMKIIa mRNA has been associated with Stau2-RNPs (Fritzsche et al., 2013; Jeong et al., 2007) , we investigated whether intron i16 could interact with Stau2. Co-expression of exogenous FLAG-Stau2 and ZsGreen fused to intron i16 showed significant enrichment of i16 sequences in the Stau2 immunoprecipitates (IPs) compared to other well-known RBPs ( Figure 3D and S3B). Moreover, this enrichment was not obtained with a non-retained intron such as i9 ( Figure 3E ). Next, we tried to confirm the interaction at endogenous level in brain extracts using two specific antibodies against Stau1 and Stau2. In agreement with overexpression experiments, we found that i16-containing mRNA was specifically enriched in the Stau2 IP compared to control IP and Stau1 IP samples ( Figure 3F ). Of the different splicing variants of Stau2 (Monshausen et al., 2004 ) (see input sample in Figure S3C ), our IPs (Stau2-IP) mostly contained the largest isoforms, which have an extended C-terminal domain that might interact with a greater variety of RNA granule components than the shorter isoforms (Miki et al., 2011) . We also corroborated the endogenous interaction between intron i16 and Stau2 in cortical neurons ( Figure S3D ), indicating that this interaction occurs in different neuronal models. of Stau2 downregulation ( Figure 4A ) on nuclear and cytoplasmic i16 levels in short hairpin RNA (shRNA)-expressing cortical neurons. To monitor our subcellular fractionation procedures, we analyzed a nuclear mRNA (Malat1) and a cytoplasmic mRNA (Gapdh) ( Figure S4A ). As shown in Figure 4B , cytoplasmic i16-containing mRNA levels decreased significantly in Stau2-knockdown compared to control neurons. Notably, this decrease was not observed in nuclear samples, suggesting that Stau2 does not exert any effect on transcription or nuclear stability of i16-containing mRNA. To directly assess whether Figure S3B . (E) HEK293T cells were co-transfected with vectors expressing either ZsGreen-i16 or ZsGreen-i9 and Stau2-FLAG or empty vector as control. FLAG IPs were used to quantify ZsGreen-i16 and ZsGreen-i9 mRNA enrichment over input by qRT-PCR. Nonspecific binding to the beads was corrected by measuring the levels of the nonrelated TBP mRNA. Relative mean (n = 3) and SEM values are shown. (F) Adult mice brain extracts (input) were immunoprecipitated with an anti-Stau2 antibody (Stau2 IP), anti-Stau1 antibody (Stau1 IP), or preimmune antisera (Ctrl IP) as control. Samples were used to quantify the enrichment levels over input of i16-containing CaMKIIa mRNA by qRT-PCR. Mean (n = 3) and SEM values are plotted. Input and IPs were analyzed by western blot to detect endogenous expression of Stau1 and Stau2 and IP efficiencies (see Figure S3C ). these changes in cytoplasmic RNA levels were a result of altered stability, we examined the half-life of i16-containing mRNA in Neuro-2a cells in which Stau2 was downregulated (shStau2). After transcriptional blockade with actinomycin D, i16-containing transcripts were significantly lower in shStau2-transfected cells than shCtrl-expressing cells ( Figure 4C ). In agreement with this result, the overexpression of Stau2 increased the stability of i16-containing mRNA ( Figure S4B ). To confirm the effect of Stau2 downregulation, we analyzed the presence of intron i16 in dendrites of hippocampal neurons by high-resolution FISH imaging and found that the percentage of i16-containing foci decreased by more than 50% under Stau2-knockdown conditions ( Figure 4D ). By contrast, we did not observe a significant downregulation of spliced CaMKIIa mRNA in the same samples ( Figures S4C and S4D) . Together, our results strongly suggest that Stau2 has a role in stabilizing and transporting i16-containing CaMKIIa mRNA in dendrites.
DISCUSSION
Our study provides new insights into the possible functions of intron retention in synaptic plasticity. Using two orthogonal approaches, we have demonstrated the presence of i16-containing CaMKIIa mRNAs in dendrites and synaptoneurosomes. Furthermore, we have found that intron i16 interacts with the RNA granule marker, Stau2 protein. Our data support the idea that the association between intron i16 and Stau2 enhances the dendritic localization of i16-containing CaMKIIa transcripts, likely through the assembly of these transcripts into RNA granules.
New advances in RNP granule assembly mechanisms indicate that RNA could provide the local environment to polymerize different sets of proteins into a unique RNA granule for achieving its cellular fate. In this regard, our RIP experiments suggest that intron 16 and mature CaMKIIa mRNA would share common interacting proteins present in the same RNP particles. Stau2 could play such a role either by forming domain-swapping homodimers (Park and Maquat, 2013) or through indirect complex interactions within the same RNA granule. Interestingly, CaMKIIa mRNA has been found enriched in granules associated to lowcomplexity (LC) domain proteins from mouse brain , supporting the idea that LC domains described in Stau proteins could be important for RNP formation and dynamics.
Retained introns harbor sequences that may bind regulatory proteins to determine dendritic localization (Buckley et al., 2014) . It is intriguing that the first 120 nt of intron i16 are strongly conserved between rodents and humans, which suggests that the 5 0 end of intron i16 could be a target of specific proteins modulating its retention and/or localization. In this regard, the 5 0 exon-intron boundary sequence of i16 is extremely rare compared to consensus sequences of U12-and U2-type introns (Turunen et al., 2013) , and weak 5 0 splice sites are typically characteristic of retained introns (Sakabe and de Souza, 2007) .
Our results suggest a specific role for intron i16 in a subpopulation of CaMKIIa RNPs. In this regard, different BDNF mRNA splice variants are targeted to distinct cellular compartments (Baj et al., 2011) , and only 10% of total b-actin mRNAs are actively transported to distal dendrites (Park et al., 2014) , where they show specific burst-like patterns of translation under stimulatory conditions (Wu et al., 2016) . We have found that i16-retained mRNA levels are downregulated upon synaptic stimulation in a translation-dependent manner. As it leads to increased CaMKIIa mRNA local translation (Aakalu et al., 2001) , synaptic activation could trigger degradation of i16-containing mRNA by NMD, where indeed Stau2 could play a key role (Miki et al., 2011; Park and Maquat, 2013) . Similarly to the regulation of Robo3 in axon guidance (Colak et al., 2013) , synaptic stimulation would trigger a pioneer round of translation of the i16-contaning CaMKIIa mRNA and temporarily produce a protein isoform lacking the association domain, which would be particularly suitable for triggering a transient wave of diffusible CaMKIIa kinase activity at the synapsis (Stratton et al., 2014) .
Another possibility is that intron i16 contains microRNAresponse elements. Such elements could act as decoys or sponges in a manner similar to competitive endogenous RNA (Wong et al., 2016) . Interestingly, components of the RNAinduced silencing complex (RISC) have been found in Stau2 RNA granules in dendrites (Fritzsche et al., 2013) . Moreover, downregulation of MOV10, a key component of RISC, causes changes in the translation-active fraction of the CaMKIIa mRNA (Banerjee et al., 2009) .
In summary, our data provide the first evidence of a specific interaction between a retained intron and the Stau2 protein to enhance dendritic localization of mRNAs. Given the important role of CaMKIIa in synaptic plasticity, our findings point to the idea that intron retention would add an additional layer of regulation to fine-tune CaMKIIa at synapses in both space and time for proper neuronal function.
EXPERIMENTAL PROCEDURES Primary Neuron Cultures and Synaptoneurosomal Fractions
Dissociated mouse hippocampal and cortical neurons from E17.5 mice were cultured as described previously (Pedraza et al., 2014) . See Supplemental Experimental Procedures for more information. Animal experimental procedures were approved by the ethics committee of the National Research Council of Spain (CSIC).
Quantitative and Semiquantitative RT-PCR
Methods used for quantitative and semiquantitative PCR have been described (Pedraza et al., 2014) . All samples were treated with RNase-free DNase I (Thermo Scientific), and DNA contamination levels were assessed by qRT-PCR, omitting reverse transcriptase. In intronic disequilibrium analysis, qPCR results were corrected for primer efficiency using genomic DNA as template, and data were finally made relative to the intron with the lowest levels detected. A list of gene-specific primers can be found in Supplemental Experimental Procedures.
High-Resolution RNA In Situ Hybridization
Single-molecule mRNA detection was performed as described previously (Cajigas et al., 2012) , with minor modifications (Supplemental Experimental Procedures). Signal quantification was performed using FociJ, a plugin with specific procedures that uses object libraries supplied in ImageJ (Wayne Rasband, NIH) to detect high-intensity foci as pixel groups markedly brighter compared to background. In addition to basic statistics on foci number, size, and brightness from different channels, this plugin provides with the minimal distances between foci and a neuronal tracking signal (usually a Map2 immunofluorescence field) to discard false positives. FociJ software is available upon request.
RNA Immunoprecipitation
RNA immunoprecipitation from cell extracts crosslinked with formaldehyde was performed as described previously (Moran et al., 2012) . Further details are available in Supplemental Experimental Procedures. Figure 1F . cells/cm 2 for imaging experiments. Neuron transfection and lentivirus production protocols were as described (Pedraza et al., 2014) . Lentiviruses encoding Stau2 and scrambled shRNAs were kind gifts from M. Kiebler. For imaging neuronal dendrites and cell bodies separately, PDMS microfluidic chambers (AX50010 AXIS™ Axon Isolation Device, 500 "m, Millipore) were placed onto cover glasses coated with poly-L-lysine and neurons were then plated with 5 "l/well at 5x10 6 neurons/ml (Taylor et al., 2010) . In this device neurons are loaded into a channel with a set of microgrooves whose dimensions (approximately 5 µm in height by 10 µm in width) are selected because they prevent cell bodies from flowing through while allowing passage to dendrites and axons. As microgroove lenght is 500 µm, dendrites can extend completely.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Preparation and stimulation of functional synaptoneurosomes by Percoll gradient. Synaptoneurosomes were obtained as previously described (Nagy and Delgado-Escueta, 1984) , with some modifications. Synaptoneurosomes were obtained from cultured cortical neurons (14 DIV) or adult mice cortex (~5 weeks). Prior to homogenization, cultured neurons were collected with a cell scrapper, while brain cortex was chopped into small pieces in ice-cold homogenization buffer (0.32 M sucrose, 1 mM EDTA, 1 mg/ml BSA, 5 mM HEPES pH 7.4 in DEPC-treated water). Tissue was then homogenized with the aid of a glass-teflon douncer, with 10 strokes at 650 rpm. The homogenate (crude extract, CE) was centrifuged at 3000g for 10 min to remove cell debris, yielding P1 and S1, this supernatant was centrifuged again at 14000g for 12 min. The pellet was resuspended in Krebs HEPES buffer (150 mM HCl, 3 mM KCl, 10 mM glucose, 2 mM MgSO 4 , 2 mM CaCl 2 , 10 mM HEPES pH 7.4), and Percoll was added to 45% v/v and mixed carefully by inverting the tube. After spinning samples for 2 min at 14000 g, synaptoneurosomes were recovered from the upper layer, washed once in Krebs HEPES buffer and centrifuged again for 30 sec at 14000g. The final pellet containing synaptoneurosomes (Syn) was resuspended in Krebs HEPES buffer to 1"g/"l for stimulation. Synaptoneurosomes were incubated for 30 min at 37ºC in BDNF (100 ng/"l) or NMDA (50 "g/ml).
Cortical neurons stimulation and obtention of synaptoneurosomal fraction by filtration. Primary cortical cultures (18 DIV) were treated with actinomycin D (10 "g/ml) for 1h before stimulation to avoid any possible transcriptional effect. Selected plates were stimulated for 30 min with BDNF (200 ng/ml) and, where indicated, cycloheximide (25 "g/ml) was applied 5 min prior BDNF stimulation. After culture treatment, plates were washed twice in ice-cold PBS-MC (1xPBS supplemented with 1 mM magnesium chloride and 0.1 mM calcium chloride). Neurons were collected with a cell scrapper in homogenization buffer (118 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 2.5 mM CaCl2, 1.53 mM KH2PO4, 212.7 mM glucose, 1 mM DTT, pH 7.4, protease and phosphatase inhibitors and 40 U/ml RNase inhibitor). Collected cells were homogenated by four gentle strokes in a glass-teflon douncer on ice. Homogenate was passed two times through 100 "m nylon mesh filters (Millipore) and two times through a 5 "m PVDF membrane (Millipore). Filtrate was centrifuged at 1000 g for 10 min at 4ºC and RNA was obtained from synaptosomal containing pellet using TRI reagent (Sigma). RNA was analyzed by RT-qPCR. Gapdh mRNA was used to normalize samples. RNA immunoprecipitation. Cells were collected by trypsinization and, when required, treated with 0.3% formaldehyde for 10 min and quenched with 0.125 M Glycine. After a washing step, samples were resuspended in RIP buffer (DEPC-treated water containing 20 mM HEPES pH 7.4, 150 mM NaCl, 1 mM MgCl 2 , 0.1% Triton X-100, 10% glycerol, 0.5 mM DTT, 1# protease inhibitor cocktail (Roche), and 40 U/ml RNase inhibitor), sonicated and centrifuged at 10000 g for 10 min to remove cell debris. Supernatants were then incubated with anti-FLAG M2 beads (Sigma) for 4 h at 4ºC and, after washing steps, RNA was collected in TRK buffer (E.Z.N.A. total RNA Kit I; Omega Bio-Tek). Endogenous CaMKII! or reporter ZsGreen mRNA levels in IPs were made relative to input to correct for differences in extract concentration between conditions. Unspecific binding to beads was corrected by measuring the levels of TBP as non-related mRNAs. For endogenous RNA immunoprecipitation from brain, tissue was homogenated using a glass-teflon douncer and, as we were interested in cytoplasmatic interactions, homogenate (Crude extract, CE) was centrifuged at 1000g for 10 min and supernatant was centrifuged again at 10000g for 10 min. This second supernatant (S2) was used as input for the IP and checked for nucleus contamination by western blot as in Figure 1D . Input samples were pre-cleared with protein A beads (Protein A Sepharose CL-4B, GE Healthcare) and sequentially incubated with !Stau1or !Stau2 antibodies (M. Kiebler) or a control IgG for 3 h, and protein A beads for 1h. Endogenous i16 containing CaMKII! mRNA in IPs and unspecific binding to beads were made relative to the other introns.
Preparation of RNA granules from brain. We followed essentially a published protocol (Cambray et al., 2009) . Briefly, brains were homogenized in IMAC buffer (20 mM HEPES, pH 7.4, 140 mM potassium acetate, 1 mM magnesium acetate, 1 mM EGTA, protease and phosphatase inhibitors and 40 U/ml RNase inhibitor). The homogenate was fractionated by successive centrifugation steps to yield the indicated pellets (P) and supernatants (S). Total extracts were centrifuged at 1000 g for 10 min, giving rise to S1 and P1. The S1 supernatant was centrifuged at 10000 g for 10 min, yielding S2 and P2. The S2 supernatant was centrifuged at 100000 g for 1 h, resulting in S3 and RNA granules containing pellet P3.
